Released on May 18, 2022, Martin Shkreli gained notoriety as the former pharmaceutical executive who acquired and raised the price of Daraprim, a crucial drug used for treating toxoplasmosis, by 5,000%, sparking immense public outrage. His infamous reputation earned him the moniker "Pharma Bro."
The Martin Shkreli Chronicles: Test Your Knowledge on the Infamous Pharma Bro